NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer (NECTAR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by The Methodist Hospital System
Sponsor:
Information provided by (Responsible Party):
The Methodist Hospital System
ClinicalTrials.gov Identifier:
NCT01931163
First received: August 26, 2013
Last updated: March 14, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)